Diet Interventions in Psoriatic Arthritis
| 対象疾患 | Psoriatic Arthritis |
|---|---|
| 相 | 該当なし |
| スポンサー | University of Pennsylvania |
| ステータス | 完了 |
| 参加者数 | 92 名 |
| 介入（薬剤） | Diet 1, Diet 2 |
| 開始日 | 2021年3月11日 |
| 完了日 | 2024年11月25日 |
| 結果公開日 | 2026年6月29日 |
概要
The purpose of this study is to learn whether changing diet impacts psoriatic arthritis (PsA).
Change in Disease Activity in Psoriatic Arthritis (DAPSA)
| Mediterranean (MED) Diet | -2.1 score on a scale |
|---|---|
| DASH-LC (Low Calorie) Diet | -6.5 score on a scale |
| Standard of Care (Control) | -5.0 score on a scale |
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab i — UCB Biopharma SRL
- A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoria — Janssen Pharmaceutical K.K.
- A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoria — Janssen Research & Development, LLC
- A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects Wi — UCB Biopharma SRL
- A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With A — UCB Biopharma SRL
- The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis — Hangzhou Highlightll Pharmaceutical Co., Ltd